Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 38
2010 132
2011 130
2012 122
2013 125
2014 122
2015 146
2016 142
2017 123
2018 128
2019 55
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

1,086 results
Results by year
Filters applied: . Clear all
Page 1
Histone Deacetylase Inhibitors as Anticancer Drugs.
Eckschlager T, Plch J, Stiborova M, Hrabeta J. Eckschlager T, et al. Int J Mol Sci. 2017 Jul 1;18(7):1414. doi: 10.3390/ijms18071414. Int J Mol Sci. 2017. PMID: 28671573 Free PMC article. Review.
Histone Deacetylase Inhibitors in Cancer Therapy.
Sun Y, Sun Y, Yue S, Wang Y, Lu F. Sun Y, et al. Curr Top Med Chem. 2018;18(28):2420-2428. doi: 10.2174/1568026619666181210152115. Curr Top Med Chem. 2018. PMID: 30526462 Review.
The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence.
Moschos MM, Dettoraki M, Androudi S, Kalogeropoulos D, Lavaris A, Garmpis N, Damaskos C, Garmpi A, Tsatsos M. Moschos MM, et al. Anticancer Res. 2018 Jul;38(7):3817-3824. doi: 10.21873/anticanres.12665. Anticancer Res. 2018. PMID: 29970501 Review.
Histone Deacetylase Inhibitors and Diabetic Kidney Disease.
Hadden MJ, Advani A. Hadden MJ, et al. Int J Mol Sci. 2018 Sep 5;19(9):2630. doi: 10.3390/ijms19092630. Int J Mol Sci. 2018. PMID: 30189630 Free PMC article. Review.
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.
Damaskos C, Garmpis N, Valsami S, Kontos M, Spartalis E, Kalampokas T, Kalampokas E, Athanasiou A, Moris D, Daskalopoulou A, Davakis S, Tsourouflis G, Kontzoglou K, Perrea D, Nikiteas N, Dimitroulis D. Damaskos C, et al. Anticancer Res. 2017 Jan;37(1):35-46. doi: 10.21873/anticanres.11286. Anticancer Res. 2017. PMID: 28011471 Review.
Modulation of antitumor immunity with histone deacetylase inhibitors.
McCaw TR, Randall TD, Forero A, Buchsbaum DJ. McCaw TR, et al. Immunotherapy. 2017 Dec;9(16):1359-1372. doi: 10.2217/imt-2017-0134. Immunotherapy. 2017. PMID: 29185390 Free PMC article. Review.
Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis.
Dooley D, van Timmeren MM, O'Reilly VP, Brady G, O'Brien EC, Fazekas B, Hickey FB, Leacy E, Pusey CD, Tam FWK, Mehrling T, Heeringa P, Little MA. Dooley D, et al. Kidney Int. 2018 Nov;94(5):926-936. doi: 10.1016/j.kint.2018.05.028. Epub 2018 Aug 26. Kidney Int. 2018. PMID: 30158055 Free article.
Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma.
Spartalis E, Athanasiadis DI, Chrysikos D, Spartalis M, Boutzios G, Schizas D, Garmpis N, Damaskos C, Paschou SA, Ioannidis A, Tsourouflis G, Dimitroulis D, Nikiteas NI. Spartalis E, et al. Anticancer Res. 2019 Mar;39(3):1119-1127. doi: 10.21873/anticanres.13220. Anticancer Res. 2019. PMID: 30842140 Review.
1,086 results
Jump to page
Feedback